Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 81.88% is in line with its 5-year average of 77.69%, near the high end of its 5-year range (61.49%–83.60%).
0.25% below its 12-month average of 82.09%.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 83.60%.
GROSS MARGIN
81.88%
GROSS MARGIN AVG TTM
82.09%
GROSS MARGIN AVG 3Y
82.22%
GROSS MARGIN AVG 5Y
77.69%
GROSS MARGIN AVG 10Y
79.81%
GROSS MARGIN AVG 15Y
80.36%
GROSS MARGIN AVG 20Y
80.66%
CURRENT VS TTM AVG
-0.25%
CURRENT VS 3Y AVG
-0.42%
CURRENT VS 5Y AVG
+5.39%
CURRENT VS 10Y AVG
+2.60%
CURRENT VS 15Y AVG
+1.89%
CURRENT VS 20Y AVG
+1.51%
SECTOR MEDIAN · HEALTHCARE
58.99%
median of 90 covered companies
CURRENT VS SECTOR MEDIAN
+38.79%
vs the sector median at left
Market Cap
$226.62B
Gross Margin
40.37%
TTM Avg
39.50%
3Y Avg
40.36%
5Y Avg
43.54%
Market Cap
$178.44B
Gross Margin
79.59%
TTM Avg
78.55%
3Y Avg
78.10%
5Y Avg
78.28%
Market Cap
$176.43B
Gross Margin
56.80%
TTM Avg
53.17%
3Y Avg
51.86%
5Y Avg
51.92%
Market Cap
$336.71B
Gross Margin
73.73%
TTM Avg
73.81%
3Y Avg
73.64%
5Y Avg
72.52%
Market Cap
$344.27B
Gross Margin
22.49%
TTM Avg
20.43%
3Y Avg
22.48%
5Y Avg
23.36%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| AstraZeneca PLC (AZN) | $248.40B | 81.88% | 82.09% | 82.22% | 77.69% |
| Thermo Fisher Scientific Inc. (TMO)vs › | $226.62B | 40.37% | 39.50% | 40.36% | 43.54% |
| Amgen Inc. (AMGN)vs › | $203.66B | 72.65% | 66.16% | 69.53% | 71.51% |
| Novo Nordisk A/S (NVO)vs › | $191.26B | 80.64% | 82.83% | 83.54% | 83.48% |
| Gilead Sciences, Inc. (GILD)vs › | $178.44B | 79.59% | 78.55% | 78.10% | 78.28% |
| Abbott Laboratories (ABT)vs › | $176.43B | 56.80% | 53.17% | 51.86% | 51.92% |
| Roche Holding AG (RHHBY)vs › | $336.71B | 73.73% | 73.81% | 73.64% | 72.52% |
| Pfizer Inc. (PFE)vs › | $157.99B | 71.32% | 68.05% | 62.23% | 63.06% |
| UnitedHealth Group Incorporated (UNH)vs › | $344.27B | 22.49% | 20.43% | 22.48% | 23.36% |
| Merck & Co., Inc. (MRK)vs › | $355.49B | 75.38% | 74.15% | 73.03% | 71.89% |
Gross Margin
81.9%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 83.60% |
| 2026-03-31 | 82.48% |
| 2025-12-31 | 79.89% |
| 2025-09-30 | 81.56% |
| 2025-06-30 | 82.89% |
| 2025-03-30 | 83.51% |
| 2024-12-31 | 81.70% |
| 2024-09-30 | 77.29% |
| 2024-06-30 | 83.13% |
| 2024-03-31 | 82.51% |
| 2023-12-31 | 80.81% |
| 2023-09-30 | 81.77% |
| 2023-06-30 | 82.83% |
| 2023-03-31 | 82.49% |
| 2022-12-31 | 74.12% |
| 2022-09-30 | 72.85% |
| 2022-06-30 | 72.17% |
| 2022-03-31 | 69.17% |
| 2021-12-31 | 61.49% |
| 2021-09-30 | 61.92% |
| 2021-06-30 | 73.35% |
| 2021-03-31 | 74.54% |
| 2020-12-31 | 79.42% |
| 2020-09-30 | 79.17% |
| 2020-06-30 | 84.32% |
| 2020-03-31 | 77.65% |
| 2019-12-31 | 79.32% |
| 2019-09-30 | 78.91% |
| 2019-06-30 | 81.74% |
| 2019-03-31 | 79.44% |
| 2018-12-31 | 74.49% |
| 2018-09-30 | 78.41% |
| 2018-06-30 | 80.37% |
| 2018-03-31 | 78.10% |
| 2017-12-31 | 78.80% |
| 2017-09-30 | 79.96% |
| 2017-06-30 | 81.19% |
| 2017-03-31 | 83.46% |
| 2016-12-31 | 79.23% |
| 2016-09-30 | 84.21% |
| 2016-06-30 | 81.05% |
| 2016-03-31 | 83.58% |
| 2015-12-31 | 80.17% |
| 2015-09-30 | 82.49% |
| 2015-06-30 | 83.08% |
| 2015-03-31 | 79.05% |
| 2014-12-31 | 75.06% |
| 2014-09-30 | 78.59% |
| 2014-06-30 | 80.67% |
| 2014-03-31 | 77.51% |
| 2013-12-31 | 78.96% |
| 2013-09-30 | 80.19% |
| 2013-06-30 | 78.87% |
| 2013-03-31 | 80.17% |
| 2012-12-31 | 80.80% |
| 2012-09-30 | 80.93% |
| 2012-06-30 | 79.79% |
| 2012-03-31 | 81.29% |
| 2011-12-31 | 81.38% |
| 2011-09-30 | 80.60% |
| 2011-06-30 | 82.42% |
| 2011-03-31 | 83.85% |
| 2010-12-31 | 79.59% |
| 2010-09-30 | 80.70% |
| 2010-06-30 | 82.25% |
| 2010-03-31 | 80.71% |
| 2009-12-31 | 81.39% |
| 2009-09-30 | 84.60% |
| 2009-06-30 | 81.60% |
| 2009-03-31 | 82.04% |
| 2008-12-31 | 74.22% |
| 2008-09-30 | 79.61% |
| 2008-06-30 | 82.01% |
| 2008-03-31 | 80.85% |
| 2007-12-31 | 73.79% |
| 2007-09-30 | 80.35% |
| 2007-06-30 | 79.80% |
| 2007-03-31 | 79.84% |
| 2006-12-31 | 77.94% |
| 2006-09-30 | 79.45% |
| 2006-06-30 | 79.00% |
| 2006-03-31 | 78.88% |
| 2005-12-31 | 77.92% |
| 2005-09-30 | 78.49% |
| 2005-06-30 | 78.59% |
| 2005-03-31 | 75.45% |
| 2004-12-31 | 74.91% |
| 2004-09-30 | 75.57% |
| 2004-06-30 | 76.34% |
| 2004-03-31 | 77.18% |
| 2003-12-31 | 78.32% |
| 2003-09-30 | 75.54% |
| 2003-06-30 | 75.16% |
| 2003-03-31 | 76.03% |
| 2002-12-31 | 77.79% |
| 2002-09-30 | 72.83% |
